Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? No, never

被引:36
作者
Hiatt, JR [1 ]
Carmody, IC [1 ]
Busuttil, RW [1 ]
机构
[1] Univ Calif Los Angeles, Dumont UCLA Liver Transplant Ctr, Dept Surg, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1016/j.jhep.2005.07.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:573 / 577
页数:5
相关论文
共 43 条
[1]  
Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44
[2]  
Aizawa Y, 2000, CANCER, V89, P53, DOI 10.1002/1097-0142(20000701)89:1<53::AID-CNCR8>3.0.CO
[3]  
2-6
[4]  
[Anonymous], 1997, HEPATOLOGY, V26, pS2
[5]   Resection prior to liver transplantation for hepatocellular carcinoma [J].
Beighiti, J ;
Cortes, A ;
Abdalla, EK ;
Régimbeau, JM ;
Prakash, K ;
Durand, F ;
Sommacale, D ;
Dondero, F ;
Lesurtel, M ;
Sauvanet, A ;
Farges, O ;
Kianmanesh, R .
ANNALS OF SURGERY, 2003, 238 (06) :885-892
[6]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[7]   Prognostic prediction and treatment strategy in hepatocellular carcinoma [J].
Bruix, J ;
Llovet, JM .
HEPATOLOGY, 2002, 35 (03) :519-524
[8]   The utility of marginal donors in liver transplantation [J].
Busuttil, RW ;
Tanaka, K .
LIVER TRANSPLANTATION, 2003, 9 (07) :651-663
[9]  
*CDC, 1998, MMWR-MORBID MORTAL W, P1
[10]   Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma [J].
Cillo, U ;
Vitale, A ;
Bassanello, M ;
Boccagni, P ;
Brolese, A ;
Zanus, G ;
Burra, P ;
Fagiuoli, S ;
Farinati, F ;
Rugge, M ;
D'Amico, DF .
ANNALS OF SURGERY, 2004, 239 (02) :150-159